There’s much to be said about investing in penny stocks. This is mainly because people mistakingly assuming certain things. Just because each stock is relatively inexpensive, doesn’t mean that there is little opportunity for making gains.
While it’s perfectly natural to be wary of penny stocks, the only real concern that any investor should consider is the volatile nature of the penny stock market. Generally, investors need to purchase a large number of penny stocks to realize any profit. Therefore any movement in the market can dramatically affect one’s portfolio.
Healthcare Penny Stock #1: Soleno Therapeutics (SLNO)
When looking into investing in penny stocks, there are several industries worth looking into. The therapeutics industry is one with a high-potential for opportunities. Typically, it’s almost unheard of for a company to see its shares soar over 200%. It’s even rarer for an occurrence like this to go unnoticed. Earlier this month,
According to several market analysts, the Company’s impressive gains are thought to be connected to an announcement. It detailed their continuation of Phase 3 clinical trials, evaluating diazoxide choline controlled release (DCCR) in patients with Prader-Willi syndrome. This would be Fast Track-designated indication in the U.S. and Orphan Drug indication in the U.S. and Europe. It’s just one example of the volatile nature of penny stocks. It also shows how a bit of good news can catalyze a massive jump in share price.
Healthcare Penny Stock #2: VTV Therapeutics Inc. (VTVT)
In addition to Soleno’s outstanding performance earlier this month, VTV Therapeutics Inc (VTVT) also underwent a bullish period. The stock saw boosts of over 200% to its share price. The Company announced in December 2018 that it had exercised the right for a shareholder to purchase roughly 820,000 shares at $1.83/share. At the time of the announcement, VTV shares were trading at $1 per share.
